Efficacy and Safety of Luspatercept Treatment in Patients with Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T): A Retrospective Analysis from the Medalist Study
Year: 2020
Type: article
Source: Blood
Authors: Rami S. Komrokji, Uwe Platzbecker, Pierre Fenaux, Guillermo Garcia-Manero, Ghulam J. Mufti, Valeria Santini, Maria Diez-Campelo, Carlo Finelli, Joseph G. Jurcic, Peter L. Greenberg, Mikkael A. Sekeres, Amer M. Zeidan, Amy E. DeZern, Michael R. Savona, Jeevan K. Shetty, Rodrigo Ito, George Zhang, Xianwei Ha, Daniel Sinsimer, Jay T. Backstrom, Amit Verma
Institutions: Moffitt Cancer Center, University Hospital Leipzig, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, Université Paris Diderot, The University of Texas MD Anderson Cancer Center, King's College London, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Universidad de Salamanca, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, Stanford Cancer Institute, Stanford University, Cleveland Clinic, Yale Cancer Center, Yale University, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Bristol-Myers Squibb (United States), Acceleron Pharma (United States), Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3096492972